Literature DB >> 30124982

The Clinical-Translational Physician-Scientist: Translating Bedside to Bench.

Peter W Hunt1.   

Abstract

Translational research is often conceptualized with an implicit directionality, taking an idea generated in the laboratory (ie, the "bench") and applying it at the point of care (ie, the "bedside"). This role is often played by physician-scientists who work both in the laboratory and in the clinic. Less well appreciated is the valuable role a physician-scientist can play by using compelling observations from clinical research studies to guide basic scientists toward clinically important problems and even novel scientific concepts. The goal of this editorial is to highlight this often overlooked role that clinical-translational physician-scientists can play in translating observations at the bedside to efforts at the bench, highlighting their importance for scientific progress and discussing the type of research training and scientific environments that can help these individuals flourish. The importance of cohort studies and multidisciplinary team science in this context will also be highlighted.

Mesh:

Year:  2018        PMID: 30124982      PMCID: PMC6093316          DOI: 10.1093/infdis/jiy264

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventions.

Authors:  Joyce L Sanchez; Peter W Hunt; Cavan S Reilly; Hiroyu Hatano; Gregory J Beilman; Alexander Khoruts; Jake S Jasurda; Ma Somsouk; Ann Thorkelson; Samuel Russ; Jodi Anderson; Steven G Deeks; Timothy W Schacker
Journal:  J Infect Dis       Date:  2014-10-24       Impact factor: 5.226

2.  Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers.

Authors:  Florencia Pereyra; Janet Lo; Virginia A Triant; Jeffrey Wei; Maria J Buzon; Kathleen V Fitch; Janice Hwang; Jennifer H Campbell; Tricia H Burdo; Kenneth C Williams; Suhny Abbara; Steven K Grinspoon
Journal:  AIDS       Date:  2012-11-28       Impact factor: 4.177

3.  Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.

Authors:  Priscilla Y Hsue; Peter W Hunt; Amanda Schnell; S Craig Kalapus; Rebecca Hoh; Peter Ganz; Jeffrey N Martin; Steven G Deeks
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

4.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.

Authors:  Peter W Hunt; Jason Brenchley; Elizabeth Sinclair; Joseph M McCune; Michelle Roland; Kimberly Page-Shafer; Priscilla Hsue; Brinda Emu; Melissa Krone; Harry Lampiris; Daniel Douek; Jeffrey N Martin; Steven G Deeks
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

5.  Evidence for innate immune system activation in HIV type 1-infected elite controllers.

Authors:  Sonya Krishnan; Eleanor M P Wilson; Virginia Sheikh; Adam Rupert; Daniel Mendoza; Jun Yang; Richard Lempicki; Stephen A Migueles; Irini Sereti
Journal:  J Infect Dis       Date:  2013-11-01       Impact factor: 5.226

6.  Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers.

Authors:  Hiroyu Hatano; Steven A Yukl; April L Ferre; Erin H Graf; Ma Somsouk; Elizabeth Sinclair; Mohamed Abdel-Mohsen; Teri Liegler; Kara Harvill; Rebecca Hoh; Sarah Palmer; Peter Bacchetti; Peter W Hunt; Jeffrey N Martin; Joseph M McCune; Russell P Tracy; Michael P Busch; Una O'Doherty; Barbara L Shacklett; Joseph K Wong; Steven G Deeks
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.